Thomas F. Bishop

Thomas F. Bishop

Auto-generated profile, based on publicly available information

Thomas F. Bishop

Department of Animal Science, University of California, Davis, Davis, California, USA; Novato, California, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2022 in GEN Biotechnology
Verified
Journal Article
Open access
JTJosephine F. Trott
Josephine F. Trott
AYAmy Young
Amy Young
BMBret McNabb
Bret McNabb
XYXiang Yang
Xiang Yang
TBThomas F. Bishop
Thomas F. Bishop
AEAlison L. Van Eenennaam
Alison L. Van Eenennaam
Risk assessments of genetically modified animals include evaluating animal health and whether food products are safe and nutritious. We gathered empirical data on the health, growth, and nutritional composition of animal products from six offspring of a genome-edited (GnEd) bull homozygous for the dominant P C POLLED allele. These offspring did not differ in their growth, health, or development compared with controls. All nutrient values in the meat from control and GnEd offspring fell within the range found in beef databases. Milk composition varied within controls, between control and GnEd offspring, and over time; however, all values except sulfur percentage were within peer-reviewed literature ranges. Both meat and milk composition are influenced by breed, nutrition, parity, and days in milk. These data suggest that regulatory product composition studies should be hypothesis driven, risk based, and be prompted by novel product hazards hypothesized to result from any biochemical pathways targeted by the intended alteration.

1 April 2023 in GEN Biotechnology
Verified
Journal Article
Closed access
JLJason C. Lin
Jason C. Lin
TBThomas F. Bishop
Thomas F. Bishop
JOJoseph R. Owen
Joseph R. Owen
SHSadie L. Hennig
Sadie L. Hennig
DFDevon S. Fitzpatrick
Devon S. Fitzpatrick
AEAlison L. Van Eenennaam
Alison L. Van Eenennaam
The production of genome-edited livestock has traditionally relied on either somatic cell nuclear transfer cloning of an edited cell or microinjection of gene-editing reagents into developing embryos. Electroporation of gene-editing reagents into zygotes offers an alternative that is both high throughput and easy to use. Transfer of large (>1 kb) homology-directed repair (HDR) donor nucleic acid templates into mammalian zygotes is hindered by the thick extracellular zona pellucida (ZP) glycoprotein layer. A potentially scalable approach to deliver HDR templates of up to 4.9 kb into zygotes is to use recombinant adeno-associated virus (rAAV) vectors. In this study, electroporation conditions were optimized to efficiently deliver CRISPR-associated protein 9 (Cas9):single guide RNA (sgRNA) ribonucleoprotein (RNP) complexes to bovine and ovine zygotes, while retaining embryo viability. rAAV vectors were then used to transduce a 3.9-kb HDR template in combination with electroporation of Cas9:sgRNA RNP editing reagents 6 h postinsemination to generate bovine blastocysts with a targeted 2.7 kb knock-in (KI) at the H11 safe harbor locus. With this approach, there was no need to remove or weaken the ZP of the blastocysts that developed, and a KI rate of up to ∼38% was observed. However, to circumvent transduction of the cumulus cells, the oocytes were denuded before transduction that decreased the blastocyst development rate. In addition, genetic mosaicism was observed in the blastocysts. These results highlight that further optimization of editing approaches will be required to achieve nonmosaic embryos with a targeted KI at scale for livestock applications.